Fatigue, often described as a sense of tiredness or lack of energy, is a common complaint among patients. Despite its prevalence, fatigue remains a complex, multifaceted phenomenon that can be challenging to diagnose and manage.
Fatigue can be a symptom of various medical conditions, including anemia, thyroid disorders, sleep disorders, and chronic diseases such as diabetes and heart disease. It can also be a side effect of certain medications or the result of lifestyle factors such as stress, poor diet, and lack of exercise.
A comprehensive medical history and physical examination are crucial in the evaluation of fatigue. Lab tests, including complete blood count, thyroid function tests, and glucose levels, may also be necessary. A careful review of the patient's medications and lifestyle factors is also essential.
Treatment strategies should be individualized based on the underlying cause of fatigue. This may involve medication adjustments, lifestyle modifications, or referral to a specialist. Cognitive-behavioral therapy and graded exercise therapy have also shown promise in managing fatigue.
Understanding the multifaceted nature of fatigue is key to its effective management. By adopting a comprehensive clinical approach, healthcare professionals can better diagnose and treat this common, yet complex symptom, improving patient outcomes.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation